Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia

Affiliations

• ¹ Department of Hematology, Amsterdam University Medical Center, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands. i.vanderwerf@amsterdamumc.nl.
• ² Department of Hematology, Amsterdam University Medical Center, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
• ³ H3 Biomedicine, Inc, Boston, MA, USA.
• ⁴ MLL Munich Leukemia Laboratory, Munich, Germany.
• ⁵ Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.
• ⁶ Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
• ⁷ Department of Pediatric Oncology, Emma Children's Hospital Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.